| mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.3 |
7e-10 |
| mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-07 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-06 |
| mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-06 |
| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-06 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
2e-05 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
3e-05 |
| mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
5e-05 |